PNPLA3 and diabetes mellitus: Another study16 added PNPLA3 genotype to diabetes status (a major predictor of clinical outcomes in MASLD) in individuals with suspected MASLD based on chronic ALT elevations from both a US hospital–derived cohort and the community-based UK Biobank.107